PREVIOUS QUESTION:

 

NEXT QUESTION:

 

Who is affected by ankylosing spondylitis?

ANSWER

Ankylosing spondylitis affects about 0.1% to 0.5% of the adult population. Although it can occur at any age, spondylitis most often strikes men in their teens and 20s. It is less common and generally milder in women and more common in some Native American tribes.

SOURCES:

Spondylitis Association of America.

WebMD Health News: "FDA Approves Cymbalta for Chronic Musculoskeletal Pain."

FDA. “FDA approves Inflectra, a biosimilar to Remicade.” "FDA approves Amjevita, a biosimilar to Humira.”

Reviewed by Tyler Wheeler on December 28, 2018

SOURCES:

Spondylitis Association of America.

WebMD Health News: "FDA Approves Cymbalta for Chronic Musculoskeletal Pain."

FDA. “FDA approves Inflectra, a biosimilar to Remicade.” "FDA approves Amjevita, a biosimilar to Humira.”

Reviewed by Tyler Wheeler on December 28, 2018

NEXT QUESTION:

What are the symptoms of ankylosing spondylitis?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: